Birk Venture

Birk Venture

Birk Venture is a venture capital that is exclusively focused on the industry of life science.

Birk Venture is a private equity firm focused on investments in the life science industry. The firm was founded in 2010, in Oslo, Oslo, Norway.

Birk Venture primarily invests in healthcare initiatives like pharmaceuticals, biotechnology, diagnostics, and medical devices or instruments. The businesses and companies that Birk Ventures looks to invest in tend to be either small-sized or start-up companies.

Investment

Birk Ventures has made investments in BerGenBio, Nordic Nanovector, APIM Therapeutics, Nextera, Zelluna Immunotherapy, Onco Invent and Targovax.

They have exited their investments in BerGenBio, Targovax, Algeta, Cortendo and PCI Biotech.

Timeline

People

Name
Role
LinkedIn

Hans Ivar Robinson

CEO and Chairman

Per-Oluf Olsen

Co-Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.